Theriva Biologics
TOVX
TOVX
22 hedge funds and large institutions have $1.93M invested in Theriva Biologics in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
89% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 27
Holders
22
Holding in Top 10
–
Calls
$13.6M
Puts
–
Top Buyers
| 1 | +$118K | |
| 2 | +$88K | |
| 3 | +$49K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$24.5K |
| 5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
+$6.3K |
Top Sellers
| 1 | -$984K | |
| 2 | -$529K | |
| 3 | -$48K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$41K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$40K |